Synthetic Peptides with Inadvertent Chemical Modifications Can Activate Potentially Autoreactive T Cells
Open Access
- 15 August 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 207 (4) , 1009-1017
Abstract
The human CD8+ T cell clone 6C5 has previously been shown to recognize the tert-butyl-modified Bax161–170 peptide LLSY(3-tBu)FGTPT presented by HLA-A*02:01. This nonnatural epitope was likely created as a by-product of fluorenylmethoxycarbonyl protecting group peptide synthesis and bound poorly to HLA-A*02:01. In this study, we used a systematic approach to identify and characterize natural ligands for the 6C5 TCR. Functional analyses revealed that 6C5 T cells only recognized the LLSYFGTPT peptide when tBu was added to the tyrosine residue and did not recognize the LLSYFGTPT peptide modified with larger (di-tBu) or smaller chemical groups (Me). Combinatorial peptide library screening further showed that 6C5 T cells recognized a series of self-derived peptides with dissimilar amino acid sequences to LLSY(3-tBu)FGTPT. Structural studies of LLSY(3-tBu)FGTPT and two other activating nonamers (IIGWMWIPV and LLGWVFAQV) in complex with HLA-A*02:01 demonstrated similar overall peptide conformations and highlighted the importance of the position (P) 4 residue for T cell recognition, particularly the capacity of the bulky amino acid tryptophan to substitute for the tBu-modified tyrosine residue in conjunction with other changes at P5 and P6. Collectively, these results indicated that chemical modifications directly altered the immunogenicity of a synthetic peptide via molecular mimicry, leading to the inadvertent activation of a T cell clone with unexpected and potentially autoreactive specificities.Keywords
Funding Information
- Wellcome Trust (WT095767)
- Wellcome Trust (100326/Z/12/Z)
- Bloodwise (13054)
- Cancer Research Wales
- Wellcome Trust (ISSF Cross-Disciplinary)
This publication has 52 references indexed in Scilit:
- Decision making inxia2Acta Crystallographica Section D Structural Biology, 2013
- T-cell Receptor-optimized Peptide Skewing of the T-cell Repertoire Can Enhance Antigen TargetingJournal of Biological Chemistry, 2012
- TCR/pMHC Optimized Protein crystallization ScreenJournal of Immunological Methods, 2012
- A Single Autoimmune T Cell Receptor Recognizes More Than a Million Different PeptidesJournal of Biological Chemistry, 2012
- Molecular Mimicry as a Mechanism of Autoimmune DiseaseClinical Reviews in Allergy & Immunology, 2011
- From crystal to structure with CCP4Acta Crystallographica Section D Structural Biology, 2011
- HLA–DR1001 presents “altered‐self” peptides derived from joint‐associated proteins by accepting citrulline in three of its binding pocketsArthritis & Rheumatism, 2010
- XDSActa Crystallographica Section D Structural Biology, 2010
- Phasercrystallographic softwareJournal of Applied Crystallography, 2007
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004